Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 7/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 4/20 | 0.35 |
| ▸ | TYMS | P04818 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.32 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.32 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2035725 | 1.00 | APP (0.37) | APPNOS1PARP1NQO2TYMS | |
| SCHEMBL19213935 | 0.87 | NQO2 (0.55) | NQO2MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL23838584 | 0.80 | TDP1 (0.48) | APPNQO2TYMSCYP2C19MAPT | |
| SCHEMBL18617575 | 0.80 | TDP1 (0.50) | APPNOS1PARP1NQO2TYMS | |
| SCHEMBL24276928 | 0.80 | MAPT (0.41) | NQO2MAPTMEN1NPC1USP2 | |
| SCHEMBL13426064 | 0.77 | NQO2 (0.47) | APPNQO2CYP2C19MAPTMEN1 | |
| SCHEMBL30753426 | 0.75 | KDM4E (0.39) | APPNOS1PARP1CYP2C19MAPT | |
| SCHEMBL24465461 | 0.75 | ERBB2 (0.39) | APPNOS1PARP1MEN1NPC1 | |
| SCHEMBL19432430 | 0.75 | NPC1 (0.53) | APPMAPTMEN1NPC1POLB | |
| SCHEMBL29856246 | 0.74 | NQO2 (0.42) | APPNQO2CYP2C19ERN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3182501-B1 | ELECTROLYTE FOR NONAQUEOUS SECONDARY BATTERY AND NONAQUEOUS SECONDARY BATTERY USING THE SAME | AIST (JP) | 2020-07-15 | — | — | EP | disclosed |
| US-10340551-B2 | Electrolyte for nonaqueous secondary battery and nonaqueous secondary battery using the same | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2019-07-02 | — | — | US | disclosed |
| US-20170229738-A1 | ELECTROLYTE FOR NONAQUEOUS SECONDARY BATTERY AND NONAQUEOUS SECONDARY BATTERY USING THE SAME | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-08-10 | — | — | US | disclosed |
| EP-3182501-A1 | ELECTROLYTE FOR NONAQUEOUS SECONDARY CELL AND NONAQUEOUS SECONDARY CELL USING SAME | National Institute of Advanced Industrial Science and Technology (JP) | 2017-06-21 | — | — | EP | disclosed |
| US-9601705-B2 | Material for organic electroluminescence element and organic electroluminescence element using the same, and method for manufacturing organic electroluminescence element | UDC IRELAND LIMITED (IE) | 2017-03-21 | — | — | US | disclosed |
| US-9231251-B2 | Electrode active material and secondary battery | MURATA MANUFACTURING CO., LTD. (JP) | 2016-01-05 | — | — | US | disclosed |
| US-9231251-B2 | Electrode active material and secondary battery | MURATA MANUFACTURING CO., LTD. (JP) | 2016-01-05 | — | — | US | disclosed |
| US-20130216909-A1 | ELECTRODE ACTIVE MATERIAL AND SECONDARY BATTERY | NARD INSTITUTE, LTD. (JP) | 2013-08-22 | — | — | US | disclosed |
| US-20130216909-A1 | ELECTRODE ACTIVE MATERIAL AND SECONDARY BATTERY | NARD INSTITUTE, LTD. (JP) | 2013-08-22 | — | — | US | disclosed |
| US-8470198-B2 | Mesogenic compounds comprising discotic and calamitic groups | MERCK PATENT GMBH (DE) | 2013-06-25 | — | — | US | disclosed |
| EP-2313474-B1 | MESOGENIC COMPOUNDS COMPRISING DISCOTIC AND CALAMITIC GROUPS | MERCK PATENT GMBH (DE) | 2012-09-05 | — | — | EP | disclosed |
| US-7994423-B2 | Charge-transport materials, methods of fabrication thereof, and methods of use thereof | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-08-09 | — | — | US | disclosed |
| US-7994423-B2 | Charge-transport materials, methods of fabrication thereof, and methods of use thereof | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-08-09 | — | — | US | disclosed |
| US-20110147659-A1 | MESOGENIC COMPOUNDS COMPRISING DISCOTIC AND CALAMITIC GROUPS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-06-23 | — | — | US | disclosed |
| US-20110147659-A1 | MESOGENIC COMPOUNDS COMPRISING DISCOTIC AND CALAMITIC GROUPS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-06-23 | — | — | US | disclosed |
| US-20110147659-A1 | MESOGENIC COMPOUNDS COMPRISING DISCOTIC AND CALAMITIC GROUPS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-06-23 | — | — | US | disclosed |
| EP-2313474-A1 | MESOGENIC COMPOUNDS COMPRISING DISCOTIC AND CALAMITIC GROUPS | Merck Patent GmbH (DE) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010020312-A1 | MESOGENIC COMPOUNDS COMPRISING DISCOTIC AND CALAMITIC GROUPS | MERCK PATENT GMBH (DE) | 2010-02-25 | — | — | WO | disclosed |
| US-20090065057-A1 | Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | GEORGIA TECH RESEARCH CORPORATION | 2009-03-12 | — | — | US | disclosed |
| US-20090065057-A1 | Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | GEORGIA TECH RESEARCH CORPORATION | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090065057-A1 | Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof | SLC9A3, SLC18A2, SLC9A2 | APP 3488/4885NOS1 3856/4885PARP1 960/4885 |
| US-20110147659-A1 | MESOGENIC COMPOUNDS COMPRISING DISCOTIC AND CALAMITIC GROUPS | CALD1, DIAPH1, CALR | APP 3249/4885NOS1 3688/4885PARP1 4533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.